- Category
- Micro (2024-25)
- Udyam number
- UDYAM-WB-08-0015647

Supremacy Meditech Private Limited
About Supremacy Meditech Private Limited
Data last updated:
Supremacy Meditech Private Limited is a private limited company based in Howrah, West Bengal, India. It operates in the healthcare services segment of the healthcare sector. It was incorporated on 29 June 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U85100WB2021PTC246057.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sankha Sarkar and Sanjay Saha.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 277/1 Sarat Chatterjee Road, Howrah, West Bengal, India – 711104.
As per the financials filed for FY 2024, the company reported a revenue of ₹14.07 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹33,666 (net margin 2.4%) and EBITDA of ₹3.39 Lakh (EBITDA margin 24.1%).
As per MCA filings, the company has open charges of ₹10 Lakh on record.
Supremacy Meditech Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-08-0015647).
Company details
Recognitions & Rankings of Supremacy Meditech
Contact details
Supremacy Meditech Private Limited's registered office is in Howrah, West Bengal.
- Registered Address277/1 Sarat Chatterjee Road, Howrah, West Bengal, India – 711104
- IndustryHealthcare, Human Health Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Supremacy Meditech is hospital and medical care. In detail, this covers medical and dental practice, nursing, pathology, blood bank services, etc..
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. |
To see the full business activity and turnover split of Supremacy Meditech Private Limited, buy the company report.
Financials of Supremacy Meditech Private Limited
FY 2024 filings availableSupremacy Meditech Private Limited reported revenue of ₹14.07 Lakh (up 259% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 259% in the latest year. EBITDA rose 153% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹3.39 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹33,666 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 24.1% | ||
| Net Profit Margin | 2.4% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Supremacy Meditech Private Limited, buy the company report.
Board of directors of Supremacy Meditech Private Limited
Supremacy Meditech has 5 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sankha Sarkar Also directs: Haleness Medijunction Private Limited | Director | 29 Jun 2021 | 5 Years 4 Months | Current |
| Sanjay Saha Also directs: Haleness Medijunction Private Limited | Director | 29 Jun 2021 | 5 Years 4 Months | Current |
| Hemanta Chowdhury | Director | 17 Jan 2022 | 4 Years 9 Months | Current |
| Susovan Banerjee | Director | 17 Jan 2022 | 4 Years 9 Months | Current |
| Riya Sarkar | Director | 08 Nov 2021 | 4 Years 11 Months | Current |
Peer comparison
Supremacy Meditech Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (medical and dental practice, nursing, pathology, blood bank services, etc.), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tela Dental Clinic and Research Centre Private Limited | ₹14.62 Lakh (FY 2024) | 43.0% | Ajmer, Rajasthan, India | |||
| Diagnostix Pathology Centre Private Limited | ₹14.5 Lakh (FY 2024) | 4.0% | New Delhi, Delhi, India | |||
| Prerna Pathology Private Limited | ₹14.24 Lakh (FY 2019) | 5.0% | Odhav Ahmedabad, Gujarat, India | |||
| Eves Scan Centre Private Limited | ₹14.23 Lakh (FY 2025) | 26.0% | Uttar Pradesh, India | |||
| Diagkare Health Private Limited | ₹14.09 Lakh (FY 2024) | Ernakulam, Kerala, India | ||||
| Supremacy Meditech Private Limitedthis company | ₹14.07 Lakh (FY 2024) | ₹33,666 | 2.4% | 259.0% | Howrah, West Bengal, India | |
| Health Screen Private Limited | ₹14.03 Lakh (FY 2024) | 19.0% | Delhi, India | |||
| MP Sai Enterprise Private Limited | ₹14.02 Lakh (FY 2016) | -2.0% | Mumbai, Maharashtra, India | |||
| Mivl Manglam Invitro Private Limited | ₹14.02 Lakh (FY 2024) | -96.0% | Rajkot, Gujarat, India | |||
| Lalji Healthcare Private Limited | ₹14.01 Lakh (FY 2024) | -82.0% | Amritsar, Punjab, India | |||
| S-Dacc Health Care Private Limited | ₹13.98 Lakh (FY 2025) | -80.0% | Jayanagar, Karnataka, India |
To see the full peer comparison of Supremacy Meditech Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Feb 2025 | 101056212 | Indian Overseas Bank | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Supremacy Meditech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Supremacy Meditech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Supremacy Meditech Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Supremacy Meditech Private Limited has 6 board changes on record since 2021: 5 appointments and 1 cessation. The latest: Bapi Rai ceased to be Director on 17 Jan 2022.
Frequently asked questions
Supremacy Meditech is an active private limited company based in Howrah, West Bengal, India. The company works in human health activities, within the healthcare industry. It was incorporated on 29 June 2021 (5+ years old) and is registered under CIN U85100WB2021PTC246057.
Supremacy Meditech has 5 current directors:
- Sankha Sarkar - Director
- Sanjay Saha - Director
- Hemanta Chowdhury - Director
- Susovan Banerjee - Director
- Riya Sarkar - Director
The latest financial statements of Supremacy Meditech on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Supremacy Meditech is U85100WB2021PTC246057. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Supremacy Meditech was incorporated on 29 June 2021, making it 5+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Supremacy Meditech by revenue are Tela Dental Clinic and Research Centre Private Limited, Diagnostix Pathology Centre Private Limited, Prerna Pathology Private Limited, Eves Scan Centre Private Limited, Diagkare Health Private Limited and 5 more, all in the same principal business activity (medical and dental practice, nursing, pathology, blood bank services, etc.).
Bapi Rai ceased to be Director on 17 Jan 2022. Hemanta Chowdhury was appointed as Director on 17 Jan 2022. Susovan Banerjee was appointed as Director on 17 Jan 2022. Supremacy Meditech has 6 board changes on record in total.
Yes, Supremacy Meditech is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-08-0015647).
The registered office of Supremacy Meditech is at 2771 Sarat Chatterjee Road, Howrah, West Bengal, India – 711104.
Supremacy Meditech operates in the healthcare industry, in the human health activities segment.
Supremacy Meditech has open charges of ₹10 Lakh and no satisfied charges on record as per latest MCA filings.

